Annual report pursuant to Section 13 and 15(d)

Acquisition - Additional Information (Detail)

v3.3.1.900
Acquisition - Additional Information (Detail)
 1 Months Ended 12 Months Ended
Sep. 30, 2015
USD ($)
Jun. 30, 2015
USD ($)
Nov. 30, 2015
USD ($)
$ / Unit
May. 31, 2015
USD ($)
Business Acquisition [Line Items]        
Asset Purchase Agreement, cash paid     $ 375,374  
Note payable to seller     $ 1,176,367  
License Agreement [Member]        
Business Acquisition [Line Items]        
Useful lives     10 years  
Customer Relationships [Member]        
Business Acquisition [Line Items]        
Useful lives     15 years  
Asset Purchase Agreement [Member]        
Business Acquisition [Line Items]        
Asset Purchase Agreement, purchase price less cash and prepaids     $ 2,400,000  
Prepaid expense paid to seller by purchaser     104,000  
Contingent liability, reduced amount $ 149,175      
Asset Purchase Agreement, cash and inventory paid     1,553,272  
Asset Purchase Agreement, cash paid     375,374  
Note payable to seller     1,300,000  
Cash paid as disbursement of funds   $ 861,783    
Transaction costs     $ 22,000  
Royalty payment per bag set unit sold | $ / Unit     5  
Fair value assumed discount rate     16.00%  
Fair value long-term sustainable growth rate     3.00%  
Asset Purchase Agreement [Member] | License Agreement [Member]        
Business Acquisition [Line Items]        
Useful lives     10 years  
Asset Purchase Agreement [Member] | Customer Relationships [Member]        
Business Acquisition [Line Items]        
Useful lives     15 years  
Asset Purchase Agreement [Member] | Minimum [Member]        
Business Acquisition [Line Items]        
Minimum annual royalties     $ 35,000  
Asset Purchase Agreement [Member] | CytoMedical [Member]        
Business Acquisition [Line Items]        
Prepaid expense paid to seller by purchaser 662,500     $ 104,000
Portion of contingent liability 225,000      
Asset Purchase Agreement, cash paid $ 586,675   $ 966,597